Efficacy and safety of onabotulinumtoxinA in pediatric patients with chronic migraine

被引：0
|
作者：
Caronna, E. [1 ]
Mas-de-les-Valls-Cerco, R. [1 ]
Gallardo, V. J. [1 ]
Gomez-Dabo, L. [1 ]
Alpuente, A. [1 ]
Torres-Ferrus, M. [1 ]
Pozo-Rosich, P. [1 ]
机构：
[1] Univ Autonoma Barcelona, Vall dHebron Hosp & Res Inst, Dept Neurol, Headache Clin, Barcelona, Spain
来源：
JOURNAL OF HEADACHE AND PAIN | 2024年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P158
引用
收藏
页数：2
相关论文
共 50 条
  • [21] OnabotulinumtoxinA for Chronic Migraine
    Blumenfeld, Andrew
    Evans, Randolph W.
    HEADACHE, 2012, 52 (01): : 142 - 148
  • [22] OnabotulinumtoxinA for Chronic Migraine
    Blumenfeld, Andrew
    Evans, Randolph W.
    HEADACHE, 2017, 57 (10): : E10 - E16
  • [23] Efficacy of Fremanezumab in Patients with Chronic Migraine Who Had Prior Use of Topiramate or OnabotulinumtoxinA
    Spierings, E. L. H.
    Yeung, P. P.
    Blankenbiller, T.
    Ning, X.
    Yang, R.
    Ma, Y.
    Bigal, M.
    Aycardi, E.
    HEADACHE, 2018, 58 : 83 - 83
  • [24] Pooled analysis of the safety and tolerability of onabotulinumtoxinA in the treatment of chronic migraine
    Diener, H. -C.
    Dodick, D. W.
    Turkel, C. C.
    Demos, G.
    DeGryse, R. E.
    Earl, N. L.
    Brin, M. F.
    EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 (06) : 851 - 859
  • [25] Efficacy of Fremanezumab in Patients With Chronic Migraine Who Had Prior Use of Topiramate or OnabotulinumtoxinA
    Yeung, Paul P.
    Spierings, Egilius L. H.
    Blankenbiller, Tricia
    Ning, Xiaoping
    Yang, Ronghua
    Ma, Yuju
    Bigal, Marcelo E.
    Aycardi, Ernesto
    NEUROLOGY, 2018, 90
  • [26] Effects of onabotulinumtoxinA treatment on efficacy, depression, anxiety, and disability in Turkish patients with chronic migraine
    Bekir Enes Demiryurek
    Devrimsel Harika Ertem
    Atilla Tekin
    Mustafa Ceylan
    Yesim Guzey Aras
    Belma Dogan Gungen
    Neurological Sciences, 2016, 37 : 1779 - 1784
  • [27] Effects of onabotulinumtoxinA treatment on efficacy, depression, anxiety, and disability in Turkish patients with chronic migraine
    Demiryurek, Bekir Enes
    Ertem, Devrimsel Harika
    Tekin, Atilla
    Ceylan, Mustafa
    Aras, Yesim Guzey
    Gungen, Belma Dogan
    NEUROLOGICAL SCIENCES, 2016, 37 (11) : 1779 - 1784
  • [28] Real-world evidence for the safety and efficacy of CGRP monoclonal antibody therapy added to OnabotulinumtoxinA treatment for migraine prevention in adult patients with chronic migraine
    Mechtler, L. L.
    Saikali, N. P.
    McVige, J.
    Hughes, O.
    Traut, A.
    Adams, A.
    HEADACHE, 2021, 61 : 176 - 177
  • [29] Real-world Evidence for the Safety and Efficacy of CGRP Monoclonal Antibody Therapy Added to OnabotulinumtoxinA Treatment for Migraine Prevention in Adult Patients with Chronic Migraine
    Mechtler, L.
    Saikali, N.
    McVige, J.
    Hughes, O.
    Traut, A.
    Adams, A.
    JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 1): : 48 - 49
  • [30] Real-World Evidence for the Safety and Efficacy of CGRP Monoclonal Antibody Therapy Added to OnabotulinumtoxinA Treatment for Migraine Prevention in Adult Patients With Chronic Migraine
    Mechtler, Laszlo
    Saikali, Nicolas
    McVige, Jennifer
    Hughes, Olivia
    Traut, Alexandra
    Adams, Aubrey
    TOXICON, 2022, 214 : S39 - S40
12345